[VRTX] QoQ Quarter Result on 31-Dec-2016 [#Q4]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
23-Feb-2017
Financial Year
2016
Quarter
31-Dec-2016 [#Q4]
Profit Trend
QoQ- 178.74%
YoY- 143.63%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Quarter Result
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
Revenue 578,165 544,135 714,718 458,706 413,783 431,608 398,080 28.21%
PBT -417,170 35,506 253,533 20,306 -42,034 -18,021 -30,617 469.56%
Tax -125,903 4,337 3,985 -7,453 503 18,130 5,485 -
NP -102,952 17,996 247,756 32,945 -41,841 -64,525 -41,631 82.77%
Tax Rate - -12.21% -1.57% 36.70% - - - -
Total Cost 681,117 526,139 466,962 425,761 455,624 496,133 439,711 33.84%
Ratio Analysis
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
NP Margin -17.81 3.31 34.66 7.18 -10.11 -14.95 -10.46 42.54%
Per Share
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
EPS -0.41 0.07 1.01 0.13 -0.17 -0.26 -0.17 79.74%
EPS Diluted -0.41 0.07 0.99 0.13 -0.17 -0.26 -0.17 79.74%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.